RPS6KB1 and prostate cancer: Importantly, ganetespib also induced degradation of IGF-IR and phosphorylated EGFR receptors, previously implicated in the pathogenesis of prostate cancer, as well as the downstream effectors AKT and p70 S6K, in LNCaP cells (Fig. 1A).